PUMA BIOTECHNOLOGY, INC.
PUMA BIOTECHNOLOGY, INC. (PBYI) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 405 transactions totaling $227.9M, demonstrating a bearish sentiment with -$118.6M in net insider flow. The most recent transaction on Feb 18, 2026 involved a transaction of 66,541 shares valued at $0.
PBYI Insider Activity Summary
Who Is Buying PBYI Stock?
No significant insider buying has been recorded for PBYI in the recent period.
Who Is Selling PBYI Stock?
No significant insider selling has been recorded for PBYI in the recent period.
Is PUMA BIOTECHNOLOGY, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PBYI is bearish with an Insider Alignment Score of 24/100 and a net flow of -$118.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PBYI Frequently Asked Questions
Understanding PBYI Insider Activity
Insider trading at PUMA BIOTECHNOLOGY, INC. (PBYI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading PBYI stock, having executed 405 transactions in the past 90 days. The most active insider is Capital Partners Gp, L.l.c. Adage (Executive), who has made 20 transactions totaling $113.0M.
Related Tools
Track PUMA BIOTECHNOLOGY, INC. Insider Activity
Get notified when executives and directors at PBYI file new Form 4 transactions